Development of a non-extracted 'two-site' immunoradiometric assay for corticotropin utilizing extreme amino- and carboxy-terminally directed antibodies.
about
Simultaneous quantification and qualification of synacthen in plasmaOpposing influences of glucocorticoids and interleukin-1beta on the secretion of growth hormone and ACTH in the rat in vivo: role of hypothalamic annexin 1Secondary adrenal insufficiency associated with autoimmune disorders: a report of twenty-five cases.A budesonide prodrug accelerates treatment of colitis in rats.Control of hypothalamic-pituitary-adrenal stress axis activity by the intermediate conductance calcium-activated potassium channel, SK4.Measuring the activity of brain adrenergic receptors in man.Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone release.Pituitary apoplexy: endocrine, surgical and oncological emergency. Incidence, clinical course and treatment with reference to 799 cases of pituitary adenomas.Sex and strain variability in the rat hypothalamo-pituitary-adrenal (HPA) axis function.Sexual dimorphism in the hypothalamo-pituitary-adrenal (HPA) axis and TNFalpha responses to phospholipase A2-related neurotoxin (from crotalus durissus terrifcus) challenge.Neuropeptide-Y stimulates pituitary-adrenal activity in fetal and adult sheep.Adrenal cortex and type II polycystic ovary syndrome.Hypothalamic-pituitary-adrenal responses to centrally administered orexin-A are suppressed in pregnant rats.Autoimmunity as the most frequent cause of idiopathic secondary adrenal insufficiency: report of 111 cases.A specific carrier substance for human corticotrophin releasing factor in late gestational maternal plasma which could mask the ACTH-releasing activity.Effects of calcitonin on human auditory and visual evoked brain potentials.Bilateral adrenal enucleation-induced changes in adenohypophyseal pro-opiomelanocortin (POMC)-related peptides synthesis and secretion: a comparative study with adrenalectomized rats.
P2860
Q28301349-0F802BCB-A528-4980-A9C5-F3825098832EQ28362092-56A6C320-896F-4002-844E-1A7EAA6B40B4Q33328515-71BCD5CB-B5E8-43F6-8F1D-4EED989869F3Q34379809-35B2F9E9-81B4-4802-BBA6-414753C55CC5Q35778134-1B0FEA68-8C4B-4436-A60A-5479767B5ABFQ36402577-00A3D72D-B545-46F9-B250-514B5F64BB83Q36606890-99FA9474-A92C-4E05-8893-45754BF336A2Q42068007-9DD384FD-5737-4A7F-864F-B2BCE4B04C02Q42486102-5FBDB9CC-753C-4618-96A9-5ABC2EB2192EQ42493797-18B77F3A-691A-42AF-B263-03C8923CE71AQ42496151-5DD12FE9-CE7B-4C40-9BD8-AD15FB478643Q42502426-B43BC660-FD1D-42C9-9924-A43F816DCE0DQ44465655-8A5043A8-07F3-4116-A083-17160C28B4F9Q44544820-873F5804-F772-42DA-93C8-F0FD51F1483EQ48108608-8553749D-D300-4D60-95B8-9033BB32AD75Q48563005-2A780BA6-284E-49C9-A834-6003F87FD65AQ48734491-66F7C68D-6AB2-47C2-A9ED-F5346CE016E8
P2860
Development of a non-extracted 'two-site' immunoradiometric assay for corticotropin utilizing extreme amino- and carboxy-terminally directed antibodies.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Development of a non-extracted ...... erminally directed antibodies.
@en
Development of a non-extracted ...... erminally directed antibodies.
@nl
type
label
Development of a non-extracted ...... erminally directed antibodies.
@en
Development of a non-extracted ...... erminally directed antibodies.
@nl
prefLabel
Development of a non-extracted ...... erminally directed antibodies.
@en
Development of a non-extracted ...... erminally directed antibodies.
@nl
P2093
P2860
P356
P1433
P1476
Development of a non-extracted ...... erminally directed antibodies.
@en
P2093
P2860
P304
P356
10.1042/BJ2180703
P407
P577
1984-03-01T00:00:00Z